These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 122594)

  • 21. [Infection and host responses. (6) Evaluation of Pseudomonas vaccine therapy in refractory infection of the respiratory and transit areas].
    Tanimoto H; Tachibana A
    Nihon Naika Gakkai Zasshi; 1982 Oct; 71(10):1384-8. PubMed ID: 6820039
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary studies on the preparation of vaccine against Psudomonas aeruginosa patients with burns].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W; Zietkiewicz W
    Pol Tyg Lek; 1978 Sep; 33(39):1533-6. PubMed ID: 100771
    [No Abstract]   [Full Text] [Related]  

  • 23. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
    Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
    Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
    Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
    Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
    [No Abstract]   [Full Text] [Related]  

  • 25. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
    Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930
    [No Abstract]   [Full Text] [Related]  

  • 26. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
    Meitert T; Meitert E; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas aeruginosa infection: pathogenesis and therapy.
    Pennington JE
    Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A polyvalent Pseudomonas vaccine.
    Sato H; Diena BB
    Rev Can Biol; 1974 Jun; 33(2):93-7. PubMed ID: 4211759
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemical components of pathogens and the mechanism of their virulence: Pseudomonas aeruginosa vaccine].
    Homma Y; Tanimoto H
    Nihon Rinsho; 1986 Sep; 44(9):2016-21. PubMed ID: 3099035
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunogenic properties and specificity of pseudomonas aeruginosa polyvalent vaccine].
    Schiller B; Lysakowska E; Owczarska K
    Med Dosw Mikrobiol; 1981; 33(2):91-6. PubMed ID: 6170849
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
    Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract]   [Full Text] [Related]  

  • 35. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
    Sachs A
    Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vaccine therapy against Pseudomonas aeruginosa].
    Kurashige T; Tomoda T
    Nihon Rinsho; 1991 Oct; 49(10):2421-4. PubMed ID: 1749099
    [No Abstract]   [Full Text] [Related]  

  • 37. [Infection and immunity in burns].
    Kolker II
    Khirurgiia (Mosk); 1980 May; (5):17-22. PubMed ID: 6772869
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudomonas vaccination and immunotherapy: an overview.
    Holder IA
    J Burn Care Rehabil; 2001; 22(5):311-20. PubMed ID: 11570530
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.